Characterization of the clinical development candidate TNG348 as a potent and selective inhibitor of USP1 for the treatment of BRCA1/2mut cancers
Antoine Simoneau, Hsin-Jung Wu, Madhavi Bandi,Katherine Lazarides, Sining Sun,Shangtao Liu, Samuel Meier, Ashley Choi,Hongxiang Zhang,Binzhang Shen,Douglas Whittington, Sirimas Sudsakorn,Wenhai Zhang,Yi Yu, Yong Liu,Colin Liang, Michael Palmieri,Yingnan Chen,Brian Haines,Alice Tsai,Minjie Zhang,Alan Huang,Jannik Andersen,Tianshu Feng, Scott Throner,John Maxwell CANCER RESEARCH（2023）
AI 理解论文
溯源树
样例
